3 stocks I’d recommend for investor portfolios after last week’s market slump

Andy Ross says last week’s dramatic market fall should be seen as an opportunity and analyses three stocks he thinks could help you generate better returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There are times when investing in stocks can be unsettling such as last week when the UK market followed other global indexes down. But to patient investors, the falls could present an opportunity to buy high-quality companies at a better price. That’s the upside of volatility. 

Fever time

One high-flying stock that was hit hard in the panic was Fevertree Drinks (LSE: FEVR). This investor favourite has produced massive investor returns since its IPO back in late 2014. A sharp deterioration in the share price that preceded last week’s market turmoil has accelerated and now this high-growth company is more affordable than it has been at any other time in the last three months.

Although it’s said that investors should never try and catch a falling knife and despite the fact Fevertree was already falling prior to the slump, it is nonetheless a stock with huge future potential. Hence the high price-to-earnings ratio. One of the directors certainly has seen the share slide as an opportunity. Kevin Havelock, a non-executive director of the company and a Unilever veteran, bought a total of 8,240 ordinary shares at a volume weighted average price of 2,948p.

Double whammy

Hays (LSE: HAS) was another stock hit harder than most by the market slump. In just the last week, the share price, which had been enjoying a strong run, has fallen by over 25%. Hays suffered more than most because it also released disappointing news during the week so saw a double whammy which may now create an opportunity for investors.

The company revealed net fee income rose 9% on a like-for-like basis in the three months ended 30 September. This was 2% short of consensus forecasts. Investors were also concerned by a slowdown, blamed on Brexit concerns, of net fees which dropped to 3% growth from 5% previously.

The steep fall in the share price means now could be an attractive entry point for investors, especially given the company’s strong performance outside the UK, such as in Germany where it recorded a 13% rise in like-for-like sales.

Brexit issues

It’s been a tough year for house-builders and Telford Homes (LSE: TEF) is no exception. The company recently warned investors that negative Brexit sentiment was affecting the housing market, with potential buyers waiting to see how the UK’s exit from the EU next March goes before making any commitment.

Focusing on London residential development, Telford is particularly vulnerable to any slowdown in the London housing market and from lower demand for expensive homes. Indeed, it said sales of £600,000+ homes had become more challenging and taken longer to secure.

But for investors comfortable with above-average market volatility and the cyclical nature of house-builders, Telford seems worth considering, especially after the latest hit to its share price. House-builder share prices are being hit by negative investor sentiment and Brexit fears. For investors willing to take a long-term view and particularly after the latest fall, it could be worth further investigation. Increasingly, the risk is being priced into the share, so investors would be taking on less risk.

One of the best ways to grow wealth is through long-term investments in stocks. Investors should look beyond short periods of market volatility and take advantage of the opportunities that sharp downturns create. 

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »